- Unique approach to challenges of chronic disease and health care spending
- Invest in companies across the consumer goods and health care value chains using theme of prevention
- Benefits from strong secular trends promoting healthy lifestyles and technological trends in diagnostics and digitization
The RobecoSAM Sustainable Healthy Living Strategy is a conviction-based, thematic strategy that captures market opportunities arising from trends in health and lifestyle. Based on a bottom-up stock selection, the strategy seeks to achieve long-term capital appreciation through exposure to healthy behavior, preventative and diagnostic care markets.
Our investment philosophy is grounded in the core belief that the integration of ESG factors into a disciplined, research-driven investment process leads to better-informed investment decisions and better risk-adjusted returns through an economic cycle.
Building on our proprietary data and research, we identify companies that generate a competitive advantage through sound business practices, efficiency improvements, and the creation of new solutions for the myriad challenges facing society over the coming decades.
Taking a long-term investment perspective, we analyze companies’ business models, market positioning and growth potential, and evaluate their financial performance and valuation. Based on this fundamental assessment, we seek to uncover attractive investment opportunities and implement them in concentrated, conviction-based equity portfolios.
Our robust and disciplined process allows for consistency in the stock selection approach whilst maintaining a strong focus on fundamental analysis to build a portfolio of high conviction stocks.
Our sustainability and thematic expertise is integrated at different stages of the investment process. The construction of the thematic universe is based on the long-term sustainability challenge that is addressed by the theme. In addition, the sustainability profile of an analyzed company influences its attractiveness in the fundamental valuation. We integrate the company’s sustainability performance in our financial analysis to estimate the stock’s fair value.
The Sustainable Healthy Living Equity strategy is managed by two seasoned portfolio managers who form part of the Thematic Investing team based in Zurich. The portfolio managers are supported by dedicated equity analysts and further thematic portfolio managers from the Thematic Investing team. The portfolio managers also have access to sector, emerging markets and sustainability analysts.
ESG Integration policy
The RobecoSAM Sustainable Healthy Living Equities strategy invests in companies that benefit from secular sociodemographic and technological trends that address the dual sustainability challenges of increasing chronic disease and health care costs. It employs systematic, bottom-up stock selection that combines proprietary Environmental, Social & Governance (ESG) data and research throughout the investment process. ESG criteria for exclusions and theme-specific suitability are applied during universe construction. An in-house Sustainability Investing (SI) research team integrates financially-material sector and company-specific sustainability analysis into investment cases. A dedicated thematic equity team incorporate SI research within fundamental analysis and stock valuations. Impact assessments of controversial incidences affecting portfolio holdings provide additional risk management. An active ownership and engagement team interacts directly with company management of fund holdings, offering additional channels for sustainable impact.
Geography: Broad Developed Markets
Index Tracked: MSCI World Index TRN
Ongoing Charges: 1.71%
Initial Charge: -
Investment Style: Large-Cap Blend
Fund Size (AUM): EUR 499.8M
Data by the open sources of the instrument provider. Last update: Jan. 2021
MSCI Sustainability Score
Source: MSCI Inc.
Last update: Jan, 2021
Morningstar Sustainability Score
Source: Morningstar, Inc.
Last update: Jan, 2021
Rolling performance, as of Dec 2020:
1 Year: 5.57%
3 Years: 7.75%
5 Years: 10.22%
Data by the open sources of the instrument provider. Last update: Dec 2020
Top 10 Holdings
Novo Nordisk A/S B
Agilent Technologies Inc.
Boston Scientific Corp.
Roche Holding AG
Deckers Outdoor Corp
Koninklijke DSM NV
UnitedHealth Group Inc.
Top portfolio holdings as of Dec 2020 | Source: instrument provider.